MG Therapies
Del Mar
About MG Therapies
MG Therapies delivers cost effective, efficacious treatments for Dry Eye Syndrome (DES) and Meibomian Gland Dysfuction. The MGrx is an in-clinic table top device that delivers three clinical treatments (Lid Debridement, Gland Expression, Anti-inflammatory Cold Therapy) effectively and at 1/4 the cost of the market leader.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Non-Equity Assistance (May 2017)
- Website: mgtherapies.net
- Phone: +1888-809-6424
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/mg-therapies-1130013 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.